Abbott
Trade Abbott 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABT
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
ABT Key Statistics
ABT News
Abbott Laboratories (NYSE:ABT) reported muted sales in the third quarter on Wednesday and narrowed its fiscal 2025 guidance. The company reported third-quarter...
Wells Fargo raised the firm’s price target on Abbott (ABT) to $146 from $142 and keeps an Overweight rating on the shares. The firm notes the company reported a...
Investors should be able to count on these stocks to deliver steady and growing income over the long term. The idea of steady money flowing in, year after year...
Analyst ratings
64%
of 33 ratingsMore ABT News
Abbott Laboratories (ABT) posted net profit margins of 31.8%, more than doubling last year’s 14% margin. Earnings jumped 142% year-over-year, outpacing the comp...
Abbott Laboratories ( (ABT) ) has released its Q3 earnings. Here is a breakdown of the information Abbott Laboratories presented to its investors. Elevate Your...
Abbott Laboratories ((ABT)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRa...
TD Cowen analyst Josh Jennings maintained a Buy rating on Abbott Laboratories today and set a price target of $145.00. Elevate Your Investing Strategy: Take adv...
Earnings Call Insights Abbott signals confidence in sustaining high single-digit sales and double-digit EPS growth into 2026, led by innovation and new product...
Shares of Abbott Laboratories fell 3% on Wednesday after the diversified health-care company delivered another less-than-stellar quarter. Revenue in the third q...
Below is Validea's guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow, ABT rates highest using our P/E/Growth Investor m...
